Condition
Hyperopia and Myopia
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT07335146Not ApplicableRecruitingPrimary
Eye Imaging for the Study of Childhood Myopia
NCT07046065Not ApplicableRecruiting
Algorithm-assisted Subjective Refraction Program Dedicated to Children
NCT06997003Not ApplicableRecruitingPrimary
Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2
Showing all 3 trials